NASDAQ:ABEO

Abeona Therapeutics Stock Predictions

etoro logo Buy ABEO
*Your capital is at risk
$5.67
-0.0200 (-0.351%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

ABEO Prediction Chart

ABEO Predictions History

Latest community submissions for ABEO.
Predictor Target Session Target Price Result Direction Accuracy Score
ANIKET MAZUMDAR ANIKET MAZUMDAR @ANIKETMAZUMDAR.129816
Dec 13, 2019 Bearish $3.65 V 1
May 7, 2019 $7.80 -96.03% $7.86 V 99.23% 2
May 6, 2019 $8.00 -96.01% $8.02 X 99.75% 5
Apr 23, 2019 $8.16 -96.04% $8.24 X 99.03% 1
Apr 22, 2019 $7.74 -96.13% $7.99 V 96.87% 0
JS JS Pro
Sep 15, 2017 $13.91 -96.77% $17.20 V 80.90% 0
Sep 15, 2017 $9.10 -97.88% $17.20 V 52.90% 0
JS JS Pro
Sep 13, 2017 $13.59 -96.12% $14.05 V 96.70% 0
Sep 13, 2017 $13.44 -96.16% $14.05 V 95.70% 0
JS JS Pro
Sep 7, 2017 $12.96 -96.26% $13.85 V 93.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABEO with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABEONA THERAPEUTICS INC.
Abeona Therapeutics
Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A; ABO-201 to treat CLN3 disease;...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE